Imidapril, an Angiotensin-Converting Enzyme Inhibitor, Inhibits Thrombosis via Reduction in Aortic Plasminogen Activator Inhibitor Type-1 Levels in Spontaneously Hypertensive Rats
スポンサーリンク
概要
- 論文の詳細を見る
It is known that angiotensin II (Ang II) exerts an antifibrinolytic effect by stimulating synthesis of plasminogen activator inhibitor type-1 (PAI-1), a specific inhibitor of tissue plasminogen activator (t-PA). The aim of this study was to compare the antithrombotic potency of imidapril, an angiotensin-converting enzyme (ACE) inhibitor, and candesartan, an angiotensin II type 1 (AT_1) receptor antagonist, in a model of arterial thromboss in spontaneously hypertensive rats (SHRs).Oral treatment with 5 mg/kg imidapril 1 h before induction of thrombosis resulted in a significant reduction in thrombus weight, whereas candesartan did not affect thrombus weight the same treatment conditions. Candesartan lowered blood pressure to the same degree as in the imidapril-treated rats. Imidapril not only reduce the serum and aortic ACE activities, but also reduced aortic PAI-1 protein levels, while candesartan had no effect on theses.These results suggest that imidapril, but not the AT_1 receptor antagonist, candesartan, enhances fibrinolysis via a reduction of aortic PAI-1 levels by inhibiting ACE and prevents thrombus formation in SHRs.
- 公益社団法人日本薬学会の論文
- 1999-08-15
著者
-
Ohtani Akio
Pharmacology Lab. Mitsubishi Tanabe Pharma Co. Ltd.
-
ODAWARA Akio
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Odawara Akio
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Mitsui Takashi
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
CHISHIMA Susumu
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.,
-
OHTANI Akio
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.,
-
Chishima Susumu
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
関連論文
- Synthesis and Evaluation of Pyrrolin-2-one Compounds, a Series of Plasminogen Activator Inhibitor-1 Inhibitors
- Synthesis of 1,4-Diphenylbutadiene Derivatives : Novel Inducer of Tissue-Type Plasminogen Activator (t-PA) in Cultured Bovine Endothelial Cells
- Inhibitory Effects of TA-993 and Its Metabolite MB3 on Platelet Activation Induced by Collagen and U-46619 in Human Platelets
- Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL from Oxidative Modification in Hypercholesterolemic Rabbits
- In Vitro Inhibitory Effects of the Optical Isomers and Metabolites of Fluvastatin on Copper Ion-Induced LDL Oxidation
- Imidapril, an Angiotensin-Converting Enzyme Inhibitor, Inhibits Thrombosis via Reduction in Aortic Plasminogen Activator Inhibitor Type-1 Levels in Spontaneously Hypertensive Rats